{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:47:18Z","timestamp":1774442838690,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T00:00:00Z","timestamp":1406160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1038\/gt.2014.66","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T10:20:28Z","timestamp":1406197228000},"page":"874-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC\/5FC therapy in human melanoma xenograft model"],"prefix":"10.1038","volume":"21","author":[{"given":"L","family":"Kucerova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Skolekova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Demkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Bohovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Matuskova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,24]]},"reference":[{"key":"BFgt201466_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mam.2006.12.001","volume":"28","author":"D Portsmouth","year":"2007","unstructured":"Portsmouth D, Hlavaty J, Renner M . Suicide genes for cancer therapy. Mol Aspects Med 2007; 28: 4\u201341.","journal-title":"Mol Aspects Med"},{"key":"BFgt201466_CR2","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/978-1-61779-815-3_30","volume":"879","author":"M Camassola","year":"2012","unstructured":"Camassola M, de Macedo Braga LM, Chagastelles PC, Nardi NB . Methodology, biology and clinical applications of human mesenchymal stem cells. Methods Mol Biol 2012; 879: 491\u2013504.","journal-title":"Methods Mol Biol"},{"key":"BFgt201466_CR3","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1517\/14712598.2010.531257","volume":"10","author":"TJ Myers","year":"2010","unstructured":"Myers TJ, Granero-Molto F, Longobardi L, Li T, Yan Y, Spagnoli A . Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opin Biol Ther 2010; 10: 1663\u20131679.","journal-title":"Expert Opin Biol Ther"},{"key":"BFgt201466_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4149\/av_2014_01_3","volume":"58","author":"E Durinikova","year":"2014","unstructured":"Durinikova E, Kucerova L, Matuskova M . Mesenchymal stromal cells retrovirally transduced with prodrug-converting genes are suitable vehicles for cancer gene therapy. Acta Virol 2014; 58: 1\u201313.","journal-title":"Acta Virol"},{"key":"BFgt201466_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1634\/stemcells.2006-0589","volume":"25","author":"A Schaffler","year":"2007","unstructured":"Schaffler A, Buchler C . Concise review: adipose tissue-derived stromal cells\u2013basic and clinical implications for novel cell-based therapies. Stem Cells 2007; 25: 818\u2013827.","journal-title":"Stem Cells"},{"key":"BFgt201466_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1089\/cbr.2011.1024","volume":"26","author":"N Serakinci","year":"2011","unstructured":"Serakinci N, Christensen R, Fahrioglu U, Sorensen FB, Dagnaes-Hansen F, Hajek M et al. Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma. Cancer Biother Radiopharm 2011; 26: 767\u2013773.","journal-title":"Cancer Biother Radiopharm"},{"key":"BFgt201466_CR7","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1021\/mp200151a","volume":"8","author":"M Cihova","year":"2011","unstructured":"Cihova M, Altanerova V, Altaner C . Stem cell based cancer gene therapy. Mol Pharm 2011; 8: 1480\u20131487.","journal-title":"Mol Pharm"},{"key":"BFgt201466_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.scr.2011.11.006","volume":"8","author":"L Kucerova","year":"2012","unstructured":"Kucerova L, Poturnajova M, Tyciakova S, Matuskova M . Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase. Stem Cell Res 2012; 8: 247\u2013258.","journal-title":"Stem Cell Res"},{"key":"BFgt201466_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2141.2004.05200.x","volume":"127","author":"J Li","year":"2004","unstructured":"Li J, Law HK, Lau YL, Chan GC . Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol 2004; 127: 326\u2013334.","journal-title":"Br J Haematol"},{"key":"BFgt201466_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10616-011-9374-5","volume":"63","author":"W Liang","year":"2011","unstructured":"Liang W, Xia H, Li J, Zhao RC . Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agents. Cytotechnology 2011; 63: 523\u2013530.","journal-title":"Cytotechnology"},{"key":"BFgt201466_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jgm.1313","volume":"11","author":"R Uchibori","year":"2009","unstructured":"Uchibori R, Okada T, Ito T, Urabe M, Mizukami H, Kume A et al. Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy. J Gene Med 2009; 11: 373\u2013381.","journal-title":"J Gene Med"},{"key":"BFgt201466_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2009.08.028","volume":"290","author":"M Matuskova","year":"2010","unstructured":"Matuskova M, Hlubinova K, Pastorakova A, Hunakova L, Altanerova V, Altaner C et al. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett 2010; 290: 58\u201367.","journal-title":"Cancer Lett"},{"key":"BFgt201466_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbrc.2012.04.050","volume":"421","author":"CH Ryu","year":"2012","unstructured":"Ryu CH, Park KY, Kim SM, Jeong CH, Woo JS, Hou Y et al. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma. Biochem Biophys Res Commun 2012; 421: 585\u2013590.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt201466_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1158\/1078-0432.CCR-12-1568","volume":"19","author":"SW Kim","year":"2013","unstructured":"Kim SW, Kim SJ, Park SH, Yang HG, Kang MC, Choi YW et al. Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK. Clin Cancer Res 2013; 19: 415\u2013427.","journal-title":"Clin Cancer Res"},{"key":"BFgt201466_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/gt.2012.12","volume":"20","author":"M Gutova","year":"2013","unstructured":"Gutova M, Shackleford GM, Khankaldyyan V, Herrmann KA, Shi XH, Mittelholtz K et al. Neural stem cell-mediated CE\/CPT-11 enzyme\/prodrug therapy in transgenic mouse model of intracerebellar medulloblastoma. Gene Therapy 2013; 20: 143\u2013150.","journal-title":"Gene Therapy"},{"key":"BFgt201466_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/157488810791824421","volume":"5","author":"M Gutova","year":"2010","unstructured":"Gutova M, Najbauer J, Chen MY, Potter PM, Kim SU, Aboody KS . Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme. Curr Stem Cell Res Ther 2010; 5: 273\u2013276.","journal-title":"Curr Stem Cell Res Ther"},{"key":"BFgt201466_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1158\/0008-5472.CAN-06-3607","volume":"67","author":"MK Danks","year":"2007","unstructured":"Danks MK, Yoon KJ, Bush RA, Remack JS, Wierdl M, Tsurkan L et al. Tumor-targeted enzyme\/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res 2007; 67: 22\u201325.","journal-title":"Cancer Res"},{"key":"BFgt201466_CR18","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/jgm.2684","volume":"14","author":"M Matuskova","year":"2012","unstructured":"Matuskova M, Baranovicova L, Kozovska Z, Durinikova E, Pastorakova A, Hunakova L et al. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells. J Gene Med 2012; 14: 776\u2013787.","journal-title":"J Gene Med"},{"key":"BFgt201466_CR19","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"DB Longley","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG . 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003; 3: 330\u2013338.","journal-title":"Nat Rev Cancer"},{"key":"BFgt201466_CR20","doi-asserted-by":"publisher","first-page":"6304","DOI":"10.1158\/0008-5472.CAN-06-4024","volume":"67","author":"L Kucerova","year":"2007","unstructured":"Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C . Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007; 67: 6304\u20136313.","journal-title":"Cancer Res"},{"key":"BFgt201466_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/mt.2009.237","volume":"18","author":"IT Cavarretta","year":"2010","unstructured":"Cavarretta IT, Altanerova V, Matuskova M, Kucerova L, Culig Z, Altaner C . Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth. Mol Ther 2010; 18: 223\u2013231.","journal-title":"Mol Ther"},{"key":"BFgt201466_CR22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jgm.1239","volume":"10","author":"L Kucerova","year":"2008","unstructured":"Kucerova L, Matuskova M, Pastorakova A, Tyciakova S, Jakubikova J, Bohovic R et al. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J Gene Med 2008; 10: 1071\u20131082.","journal-title":"J Gene Med"},{"key":"BFgt201466_CR23","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/ijc.26278","volume":"130","author":"V Altanerova","year":"2012","unstructured":"Altanerova V, Cihova M, Babic M, Rychly B, Ondicova K, Mravec B et al. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma. Int J Cancer 2012; 130: 2455\u20132463.","journal-title":"Int J Cancer"},{"key":"BFgt201466_CR24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/156800910791190184","volume":"10","author":"I Kenessey","year":"2010","unstructured":"Kenessey I, Keszthelyi M, Kramer Z, Berta J, Adam A, Dobos J et al. Inhibition of c-Met with the specific small molecule tyrosine kinase inhibitor SU11274 decreases growth and metastasis formation of experimental human melanoma. Curr Cancer Drug Targets 2010; 10: 332\u2013342.","journal-title":"Curr Cancer Drug Targets"},{"key":"BFgt201466_CR25","doi-asserted-by":"publisher","first-page":"e26753","DOI":"10.1371\/journal.pone.0026753","volume":"6","author":"GJ van Leenders","year":"2011","unstructured":"van Leenders GJ, Sookhlall R, Teubel WJ, de Ridder CM, Reneman S, Sacchetti A et al. Activation of c-MET induces a stem-like phenotype in human prostate cancer. PLoS One 2011; 6: e26753.","journal-title":"PLoS One"},{"key":"BFgt201466_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/cas.12104","volume":"104","author":"S Nishida","year":"2013","unstructured":"Nishida S, Hirohashi Y, Torigoe T, Inoue R, Kitamura H, Tanaka T et al. Prostate cancer stem-like cells\/cancer-initiating cells have an autocrine system of hepatocyte growth factor. Cancer Sci 2013; 104: 431\u2013436.","journal-title":"Cancer Sci"},{"key":"BFgt201466_CR27","doi-asserted-by":"publisher","first-page":"9951","DOI":"10.1073\/pnas.1016912108","volume":"108","author":"Y Li","year":"2011","unstructured":"Li Y, Li A, Glas M, Lal B, Ying M, Sang Y et al. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc Natl Acad Sci USA 2011; 108: 9951\u20139956.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201466_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1158\/1541-7786.MCR-07-0344","volume":"6","author":"L Xu","year":"2008","unstructured":"Xu L, Shen SS, Hoshida Y, Subramanian A, Ross K, Brunet JP et al. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol Cancer Res 2008; 6: 760\u2013769.","journal-title":"Mol Cancer Res"},{"key":"BFgt201466_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1476-4598-9-129","volume":"9","author":"L Kucerova","year":"2010","unstructured":"Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Altaner C . Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 2010; 9: 129.","journal-title":"Mol Cancer"},{"key":"BFgt201466_CR30","first-page":"245","volume":"8","author":"S Amano","year":"2011","unstructured":"Amano S, Gu C, Koizumi S, Tokuyama T, Namba H . Timing of ganciclovir administration in glioma gene therapy using HSVtk gene-transduced mesenchymal stem cells. Cancer Genomics Proteomics 2011; 8: 245\u2013250.","journal-title":"Cancer Genomics Proteomics"},{"key":"BFgt201466_CR31","first-page":"2354","volume":"4","author":"AP de Souza","year":"2012","unstructured":"de Souza AP, Bonorino C . The immune system: endogenous anticancer mechanism. Front Biosci (Elite Ed) 2012; 4: 2354\u20132364.","journal-title":"Front Biosci (Elite Ed)"},{"key":"BFgt201466_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/1078-0432.CCR-11-2186","volume":"18","author":"D Paez","year":"2012","unstructured":"Paez D, Labonte MJ, Bohanes P, Zhang W, Benhanim L, Ning Y et al. Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin Cancer Res 2012; 18: 645\u2013653.","journal-title":"Clin Cancer Res"},{"key":"BFgt201466_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene B, Berx G . Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97\u2013110.","journal-title":"Nat Rev Cancer"},{"key":"BFgt201466_CR34","first-page":"97","volume":"4","author":"JE Kim","year":"2013","unstructured":"Kim JE, Leung E, Baguley BC, Finlay GJ . Heterogeneity of expression of epithelial-mesenchymal transition markers in melanocytes and melanoma cell lines. Front Genet 2013; 4: 97.","journal-title":"Front Genet"},{"key":"BFgt201466_CR35","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.ajpath.2012.02.014","volume":"180","author":"SH Shirley","year":"2012","unstructured":"Shirley SH, Greene VR, Duncan LM, Torres Cabala CA, Grimm EA, Kusewitt DF . Slug expression during melanoma progression. Am J Pathol 2012; 180: 2479\u20132489.","journal-title":"Am J Pathol"},{"key":"BFgt201466_CR36","first-page":"841","volume":"39","author":"C Rouleau","year":"2011","unstructured":"Rouleau C, Smale R, Sancho J, Fu YS, Kurtzberg L, Weber W et al. Endosialin: a novel malignant cell therapeutic target for neuroblastoma. Int J Oncol 2011; 39: 841\u2013851.","journal-title":"Int J Oncol"},{"key":"BFgt201466_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ccr.2012.11.009","volume":"22","author":"T Brabletz","year":"2012","unstructured":"Brabletz T . EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell 2012; 22: 699\u2013701.","journal-title":"Cancer Cell"},{"key":"BFgt201466_CR38","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J . EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010; 29: 4741\u20134751.","journal-title":"Oncogene"},{"key":"BFgt201466_CR39","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12015-008-9048-7","volume":"5","author":"C La Porta","year":"2009","unstructured":"La Porta C . Cancer stem cells: lessons from melanoma. Stem Cell Rev 2009; 5: 61\u201365.","journal-title":"Stem Cell Rev"},{"key":"BFgt201466_CR40","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1021\/pr200511f","volume":"10","author":"M Rocco","year":"2011","unstructured":"Rocco M, Malorni L, Cozzolino R, Palmieri G, Rozzo C, Manca A et al. Proteomic profiling of human melanoma metastatic cell line secretomes. J Proteome Res 2011; 10: 4703\u20134714.","journal-title":"J Proteome Res"},{"key":"BFgt201466_CR41","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1600-0625.2011.01254.x","volume":"20","author":"A Mauerer","year":"2011","unstructured":"Mauerer A, Roesch A, Hafner C, Stempfl T, Wild P, Meyer S et al. Identification of new genes associated with melanoma. Exp Dermatol 2011; 20: 502\u2013507.","journal-title":"Exp Dermatol"},{"key":"BFgt201466_CR42","doi-asserted-by":"publisher","first-page":"6115","DOI":"10.1038\/onc.2010.350","volume":"29","author":"M Fukunaga-Kalabis","year":"2010","unstructured":"Fukunaga-Kalabis M, Martinez G, Nguyen TK, Kim D, Santiago-Walker A, Roesch A et al. Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population. Oncogene 2010; 29: 6115\u20136124.","journal-title":"Oncogene"},{"key":"BFgt201466_CR43","doi-asserted-by":"publisher","first-page":"584219","DOI":"10.1155\/2012\/584219","volume":"2012","author":"GE Pierard","year":"2012","unstructured":"Pierard GE, Pierard-Franchimont C, Delvenne P . Malignant melanoma and its stromal nonimmune microecosystem. J Oncol 2012; 2012: 584219.","journal-title":"J Oncol"},{"key":"BFgt201466_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.drup.2009.08.001","volume":"12","author":"MA Westhoff","year":"2009","unstructured":"Westhoff MA, Fulda S . Adhesion-mediated apoptosis resistance in cancer. Drug Resist Updat 2009; 12: 127\u2013136.","journal-title":"Drug Resist Updat"},{"key":"BFgt201466_CR45","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.3390\/ijms15033746","volume":"15","author":"MA Westhoff","year":"2014","unstructured":"Westhoff MA, Bruhl O, Nonnenmacher L, Karpel-Massler G, Debatin KM . Killing me softly\u2013future challenges in apoptosis research. Int J Mol Sci 2014; 15: 3746\u20133767.","journal-title":"Int J Mol Sci"},{"key":"BFgt201466_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4149\/neo_2013_001","volume":"60","author":"L Kucerova","year":"2013","unstructured":"Kucerova L, Skolekova S . Tumor microenvironment and the role of mesenchymal stromal cells. Neoplasma 2013; 60: 1\u201310.","journal-title":"Neoplasma"},{"key":"BFgt201466_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.biochi.2005.01.013","volume":"87","author":"UB Hofmann","year":"2005","unstructured":"Hofmann UB, Houben R, Brocker EB, Becker JC . Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 2005; 87: 307\u2013314.","journal-title":"Biochimie"},{"key":"BFgt201466_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-4598-12-22","volume":"12","author":"M Toricelli","year":"2013","unstructured":"Toricelli M, Melo FH, Peres GB, Silva DC, Jasiulionis MG . Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation. Mol Cancer 2013; 12: 22.","journal-title":"Mol Cancer"},{"key":"BFgt201466_CR49","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.febslet.2014.01.012","volume":"588","author":"N Defamie","year":"2014","unstructured":"Defamie N, Chepied A, Mesnil M . Connexins, gap junctions and tissue invasion. FEBS Lett 2014; 588: 1331\u20131338.","journal-title":"FEBS Lett"},{"key":"BFgt201466_CR50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fphys.2014.00082","volume":"5","author":"S Kurtenbach","year":"2014","unstructured":"Kurtenbach S, Zoidl G . Gap junction modulation and its implications for heart function. Front Physiol 2014; 5: 82.","journal-title":"Front Physiol"},{"key":"BFgt201466_CR51","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jss.2013.03.049","volume":"184","author":"CA Metildi","year":"2013","unstructured":"Metildi CA, Kaushal S, Hoffman RM, Bouvet M . In vivo serial selection of human pancreatic cancer cells in orthotopic mouse models produces high metastatic variants irrespective of Kras status. J Surg Res 2013; 184: 290\u2013298.","journal-title":"J Surg Res"},{"key":"BFgt201466_CR52","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1593\/neo.11948","volume":"14","author":"U Adamcic","year":"2012","unstructured":"Adamcic U, Skowronski K, Peters C, Morrison J, Coomber BL . The effect of bevacizumab on human malignant melanoma cells with functional VEGF\/VEGFR2 autocrine and intracrine signaling loops. Neoplasia 2012; 14: 612\u2013623.","journal-title":"Neoplasia"},{"key":"BFgt201466_CR53","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/neuonc\/nos158","volume":"14","author":"Y Piao","year":"2012","unstructured":"Piao Y, Liang J, Holmes L, Zurita AJ, Henry V, Heymach JV et al. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. Neuro Oncol 2012; 14: 1379\u20131392.","journal-title":"Neuro Oncol"},{"key":"BFgt201466_CR54","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1371\/journal.pmed.0040186","volume":"4","author":"TH Lee","year":"2007","unstructured":"Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK et al. Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1\/FLT1. PLoS Med 2007; 4: e186.","journal-title":"PLoS Med"},{"key":"BFgt201466_CR55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.canlet.2012.10.009","volume":"338","author":"O Shakhova","year":"2013","unstructured":"Shakhova O, Sommer L . Testing the cancer stem cell hypothesis in melanoma: the clinics will tell. Cancer Lett 2013; 338: 74\u201381.","journal-title":"Cancer Lett"},{"key":"BFgt201466_CR56","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1158\/0008-5472.CAN-13-1633","volume":"73","author":"M Das Thakur","year":"2013","unstructured":"Das Thakur M, Stuart DD . The evolution of melanoma resistance reveals therapeutic opportunities. Cancer Res 2013; 73: 6106\u20136110.","journal-title":"Cancer Res"},{"key":"BFgt201466_CR57","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham CE, Morrison SJ . Tumour heterogeneity and cancer cell plasticity. Nature 2013; 501: 328\u2013337.","journal-title":"Nature"},{"key":"BFgt201466_CR58","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/embor.2013.92","volume":"14","author":"EMF De Sousa","year":"2013","unstructured":"De Sousa EMF, Vermeulen L, Fessler E, Medema JP . Cancer heterogeneity\u2013a multifaceted view. EMBO Rep 2013; 14: 686\u2013695.","journal-title":"EMBO Rep"},{"key":"BFgt201466_CR59","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/1471-2407-13-535","volume":"13","author":"L Kucerova","year":"2013","unstructured":"Kucerova L, Skolekova S, Matuskova M, Bohac M, Kozovska Z . Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells. BMC Cancer 2013; 13: 535.","journal-title":"BMC Cancer"},{"key":"BFgt201466_CR60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4149\/neo_2011_05_361","volume":"58","author":"L Kucerova","year":"2011","unstructured":"Kucerova L, Kovacovicova M, Polak S, Bohac M, Fedeles J, Palencar D et al. Interaction of human adipose tissue-derived mesenchymal stromal cells with breast cancer cells. Neoplasma 2011; 58: 361\u2013370.","journal-title":"Neoplasma"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201466","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201466.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:16:02Z","timestamp":1648556162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,24]]},"references-count":60,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["BFgt201466"],"URL":"https:\/\/doi.org\/10.1038\/gt.2014.66","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,24]]},"assertion":[{"value":"31 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}